Skip To Main Content
Le contenu de ce site web est exclusivement réservé aux professionnels de santé en Belgique et au Luxembourg.
Campus Belgique
  • Aires thérapeutiques
  • Ressources
Campus Belgique
  • Aires thérapeutiques
  • Ressources
View Full Results

Articles

Sort by

Filtres

Réinitialiser
  • Aires thérapeutiques

From SINUS-24/SINUS-52 to Real Life: Clinical Trial Efficacy of Dupilumab in CRSwNP reinforced with DUPIREAL’s two-year real-world data

The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.3,4

Explorer

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

Explorer

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Explorer

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Explorer

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Explorer

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

Explorer

Are you ready to test your knowledge about cardiac involvement in Fabry?

Explorer

IL-4 et IL-13 : au cœur des mécanismes de l’inflammation de type 2

Explorer

Understanding Gaucher Disease: Symptoms, Classification, and Clinical Presentation

Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.1

Explorer

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Explorer

Defining ITP

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5

Explorer

Living with ITP

Patients reported significant quality of life (QoL) challenges related to their ITP1

Explorer